New endoscopic and surgical treatment options for early esophageal adenocarcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 9, 2010, Pages 1478-1484

  Gan, Susan ^a   Watson, David I ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

argon plasma coagulation; endoscopic mucosal resection; endoscopy; esophageal cancer; minimally invasive esopahgectomy; surgery

Indexed keywords

AMINOLEVULINIC ACID; ARGON;

ARGON PLASMA COAGULATION; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CRYOTHERAPY; EARLY CANCER; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PAIN; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; HUMAN; LAPAROSCOPIC SURGERY; MINIMALLY INVASIVE SURGERY; MORBIDITY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME; VAGOTOMY;

EID: 77956018343     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06421.x     Document Type: Review

References (70)

1. Kusano C, Gotoda T, Khor CJ et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J. Gastroenterol. Hepatol. 2008 23 : 1662 1665.
2. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma. Cancer Causes Control. 1996 7 : 322 327.
3. Stein HJ, Feith M, Bruecher BLDM et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann. Surg. 2005 242 : 566 575.
4. Barr H. Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer. Gut. 2003 52 : 14 15.
5. van-Laethem JL, Jagodzinski R, Peny MO et al. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy. 2001 33 : 257 261.
6. Nomura T, Miyashita M, Makino H et al. Argon plasma coagulation for the treatment of superficial esophageal carcinoma. J. Nippon. Med. Sch. 2007 74 : 163 167.
7. Akhtar K, Byrne JP, Bancewicz J et al. Argon beam plasma coagulation in the management of cancers of the esophagus and stomach. Surg. Endosc. 2000 14 : 1127 1130.
8. Ginsberg GG. Endoscopic approaches to Barrett's esophagus with high-grade dysplasia/early mucosal cancer. Best Pract. Res. Clin. Gastroenterol. 2008 22 : 751 772.
9. Kahaleh M, van-Laethem JL, Nagy N et al. Long term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy. 2002 34 : 950 955.
10. Tokar JL, Haluszka O, Weinberg DS. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. Semin. Radiat. Oncol. 2006 17 : 10 21.
11. Morris CD, Byrne JP, Armstrong GRA et al. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma coagulation. Br. J. Surg. 2001 88 : 1357 1362.
12. Spechler SJ, Davila R. Endoscopic therapy in Barrett's esophagus: when and how? Surg. Oncol. Clin. N. Am. 2009 18 : 509 521.
13. Overholt BF, Wang KK, Burdick JS et al. Five-year efficacy and safety of photodynamic therapy in Barrett's high-grade dysplasia. Gastrointest. Endosc. 2007 66 : 460 468.
14. Filonenko EV, Sokolov VV, Chissov VI et al. Photodynamic therapy of early esophageal cancer. Photodiagnosis Photodyn. Ther. 2008 5 : 187 190.
15. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc. 2003 58 : 183 188.
16. Prasad GA, Wang KK, Buttar NS et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007 132 : 1226 1233.
17. Gross SA, Wolfsen HC. The role of photodynamic therapy in the esophagus. Gastrointest. Endosc. Clin. N. Am. 2010 20 : 35 53.
18. Wani S, Puli SR, Shaheen NJ et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systemic review. Am. J. Gastroenterol. 2009 104 : 502 513.
19. Keeley SB, Pennathur A, Gooding W et al. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann. Surg. Oncol. 2007 14 : 2406 2410.
20. Kelty CJ, Ackroyd R, Brown NJ et al. Endoscopic ablation of Barrett's esophagus: a randomized-controlled trail of photodynamic therapy vs argon plasma coagulation. Aliment. Pharmacol. Ther. 2004 20 : 1289 1296.
21. Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I. Endoscopic ablation of dysplastic Barrett's esophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand. J. Gastroenterol. 2005 40 : 750 758.
22. Basu KK, Pick B, Bale R et al. Efficacy and one year follow-up of argon plasma coagulation therapy of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut. 2002 51 : 776 780.
23. Yeh RW, Triadafilopoulos G. Endoscopic therapy for Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 2005 15 : 377 397.
24. Ban S, Mino M, Nishioka NS et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising from Barrett's esophagus. Am. J. Surg. Pathol. 2004 28 : 1466 1473.
25. Pouw RE, Sharma VK, Bergman JJ et al. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy. 2008 40 : 1033 1040.
26. Ganz RA, Utley DS, Stern RA et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest. Endosc. 2004 60 : 1002 1010.
27. Pouw RE, Gondrie JJ, Curvers WL et al. Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest. Endosc. 2008 68 : 537 540.
28. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1 year follow-up of 100 patients. Gastrointest. Endosc. 2007 65 : 185 195.
29. Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5 year follow-up. Gastrointest. Endosc. 2008 68 : 867 876.
30. van-Vilsteren FGI, Bergman JJ. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus. Gastrointest. Endosc. Clin. N. Am. 2010 20 : 55 74.
31. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N. Engl. J. Med. 2009 360 : 2277 2288.
32. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the halo system. Endoscopy. 2008 40 : 370 379.
33. Pouw RE, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin. Gastroenterol. Hepatol. 2010 8 : 23 9.
34. Takizawa K, Matsuda T Kozu T, Eguchi T et al. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography. J. Gastroenterol. Hepatol. 2009 24 : 1687 1691.
35. Fujita H, Sueyoshi S, Yamana H et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J. Surg. 2001 25 : 424 431.
36. Halsey KD, Grenwald BD. Cryotherapy in the management of esophageal dysplasia and malignancy. Gastrointest. Endosc. Clin. N. Am. 2010 20 : 75 87.
37. Gossner L. The role of endoscopic resection and ablation therapy for early lesions. Best Pract. Res. Clin. Gastroenterol. 2006 20 : 867 876.
38. Pech O, May A, Rabenstein T et al. Endoscopic resection of early oesophageal cancer. Gut. 2007 56 : 1625 1634.
39. Inoue H, Minami H, Kaga M et al. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest. Endosc. Clin. N. Am. 2010 20 : 25 34.
40. Deprez PH, Aouattah T, Piessevaux H. Endoscopic removal or ablation of esophageal and gastric superficial tumours. Acta. Gastroenterol. Belg. 2006 69 : 304 311.
41. Pathirana A, Poston GJ. Lessons from Japan - endoscopic management of early gastric and esophageal cancer. Eur. J. Surg. Oncol. 2001 27 : 9 16.
42. Das A, Singh V, Fleischer DE et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am. J. Gastroenterol. 2008 103 : 1340 1345.
43. Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut. 2008 57 : 1200 1206.
44. Prasad GA, Wu TT, Wigle DA et al. Endoscopic and surgical treatment of mucosal (t1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009 137 : 815 823.
45. Yoshinaga S, Gotoda T, Kusano C et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest. Endosc. 2008 67 : 202 209.
46. Kakushima N, Fujishiro M. Endoscopic submucosal dissection for gastrointestinal neoplasms. World J. Gastroenterol. 2008 14 : 2962 2967.
47. Mizuta H, Nishimori I, Kuratani Y et al. Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis. Esophagus. 2009 22 : 626 631.
48. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. a critical review of surgery. Br. J. Surg. 1980 67 : 381 390.
49. Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br. J. Surg. 2004 91 : 943 947.
50. Stavrou EP, Smith G, Baker DF. Surgical outcomes associated with oesophagectomy in New South Wales: an investigation of hospital volume. J. Gastrointest. Surg. 2010 14 : 951 957.
51. Pennathur A, Farkas A, Krasinskas AM et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann. Thorac. Surg. 2009 87 : 1048 1055.
52. Schembre DB, Huang JL, Lin OS et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest. Endosc. 2008 67 : 595 601.
53. Stein HJ, von Rahden BH, Feith M. Surgery for early stage esophageal adenocarcinoma. J. Surg. Oncol. 2005 92 : 210 217.
54. Djärv T, Lagergren J, Blazeby JM, Lagergren P. Long-term health-related quality of life following surgery for oesophageal cancer. Br. J. Surg. 2008 95 : 1121 1126.
55. Maloney JD, Weigel TL. Minimally invasive esophagectomy for malignant and premalignant diseases of the esophagus. Surg. Clin. North. Am. 2008 88 : 979 990.
56. Okushiba S, Ohno K, Itoh K et al. Hand-assisted endoscopic esophagectomy for esophageal cancer. Surgery Today. 2003 33 : 158 161.
57. Palanivelu C, Prakash A, Senthilkumar R et al. Minimally invasive esophagectomy: thoracoscopic mobilisation of the esophagus and mediastinal lymphadenectomy in prone position - experience of 130 patients. J. Am. Coll. Surg. 2006 203 : 7 16.
58. Luketich JD, Alvelo-Rivera M, Buenaventura PO et al. Minimally invasive esophagectomy. Outcomes in 222 patients. Ann. Surg. 2003 238 : 486 495.
59. Martin DJ, Bessell JR, Chew A, Watson DI. Thoracoscopic and laparoscopic esophagectomy. Surg. Endosc. 2005 19 : 1597 1601.
60. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann. Surg. 2007 245 : 232 240.
61. Benzoni E, Terrosu G, Bresadola V et al. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management. J. Gastrointestin. Liver Dis. 2007 16 : 395 401.
62. Boettger T, Terzic A, Mueller M, Rodehorst A. Minimally invasive transhiatal and transthoracic esophagectomy. Surg. Endosc. 2007 21 : 1695 1700.
63. Berrisford RG, Wajed SA, Sanders D, Rucklidge MWM. Short-term outcomes following total minimally invasive oesophagectomy. Br. J. Surg. 2008 95 : 602 610.
64. Braghetto I, Csendes A, Cardemil G, Burdiles P, Korn O, Valladares H. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg. Endosc. 2006 20 : 1681 1686.
65. Zingg U, McQuinn A, DiValentino D et al. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann. Thorac. Surg. 2009 87 : 911 919.
66. Zingg U, Gotley DC, Smithers BM et al. Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann. Surg. Oncol. (in press).
67. Peyre CG, DeMeester SR, Rizzetto C et al. Vagal-sparing esophagectomy. The ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann. Surg. 2007 246 : 665 674.
68. DeMeester SR. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy. Ann. Thorac. Surg. 2008 85 : S747 750.
69. Akiyama H, Tsurumaru M, Ono Y et al. Esophagectomy without thoracotomy with vagal preservation (abstract). J. Am. Coll. Surg. 1994 178 : 83 5.
70. Wang D, Zhang R, Sun K. The digestive functions of the stomach after esophagectomy with vagus nerve preserved or severed in esophageal cancer patients: a comparative study (abstract). Chin. J. Oncol. 2000 22 : 414 416.